Progress in cardiovascular diseases最新文献_第6页

Inequities in atherosclerotic cardiovascular disease prevention 动脉粥样硬化性心血管疾病预防中的不公平现象。

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-05-01 DOI: 10.1016/j.pcad.2024.05.002

Sofia E. Gomez, Ramzi Dudum, Fatima Rodriguez

{"title":"Inequities in atherosclerotic cardiovascular disease prevention","authors":"Sofia E. Gomez, Ramzi Dudum, Fatima Rodriguez","doi":"10.1016/j.pcad.2024.05.002","DOIUrl":"10.1016/j.pcad.2024.05.002","url":null,"abstract":"<div><p>Atherosclerotic cardiovascular (CV) disease (ASCVD) prevention encompasses interventions across the lifecourse: from primordial to primary and secondary prevention. Primordial prevention begins in childhood and involves the promotion of ideal CV health (CVH) via optimizing physical activity, body mass index, blood glucose levels, total cholesterol levels, blood pressure, and sleep while minimizing tobacco use. Primary and secondary prevention of ASCVD thereafter centers around mitigating ASCVD risk factors via medical therapy and lifestyle interventions. Disparities in optimal preventive efforts exist among historically marginalized groups in each of these three prongs of ASCVD prevention. Children and adults with a high burden of social determinants of health also face inequity in preventive measures. Inadequate screening, risk factor management and prescription of preventive therapeutics permeate the care of certain groups, especially women, Black, and Hispanic individuals in the United States. Beyond this, individuals belonging to historically marginalized groups also are much more likely to experience other ASCVD risk-enhancing factors, placing them at higher risk for ASCVD over their lifetime. These disparities translate to worse outcomes, with higher rates of ASCVD and CV mortality among these groups. Possible solutions to promoting equity involve community-based youth lifestyle interventions, improved risk-factor screening, and increasing accessibility to healthcare resources and novel preventive diagnostics and therapeutics.</p></div>","PeriodicalId":21156,"journal":{"name":"Progress in cardiovascular diseases","volume":null,"pages":null},"PeriodicalIF":9.1,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140909654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The utility of coronary artery calcium scoring to enhance cardiovascular risk assessment for South Asian adults 冠状动脉钙化评分对加强南亚成年人心血管风险评估的实用性。

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-05-01 DOI: 10.1016/j.pcad.2024.05.001

Abhishek Gami , Sushrit Bisht , Priyanka Satish , Michael J. Blaha , Jaideep Patel

引用次数: 0

All we need to know about lipoprotein(a) 关于脂蛋白（a），我们需要知道的一切。

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-05-01 DOI: 10.1016/j.pcad.2024.05.007

Courtney Bess , Anurag Mehta , Parag H. Joshi

{"title":"All we need to know about lipoprotein(a)","authors":"Courtney Bess , Anurag Mehta , Parag H. Joshi","doi":"10.1016/j.pcad.2024.05.007","DOIUrl":"10.1016/j.pcad.2024.05.007","url":null,"abstract":"<div><p>Lipoprotein(a) [Lp(a)], a genetically determined macromolecular complex, is independently and causally associated with atherosclerotic cardiovascular disease (ASCVD) and calcific aortic stenosis via proposed proinflammatory, prothrombotic, and proatherogenic mechanisms. While Lp(a) measurement standardization issues are being resolved, several guidelines now support testing Lp(a) at least once in each adult's lifetime for ASCVD risk prediction which can foster implementation of more aggressive primary or secondary prevention therapies. Currently, there are several emerging targeted Lp(a) lowering therapies in active clinical investigation for safety and cardiovascular benefit among both primary and secondary prevention populations. First degree relatives of patients with high Lp(a) should be encouraged to undergo cascade screening. Primary prevention patients with high Lp(a) should consider obtaining a coronary calcium score for further risk estimation and to guide further ASCVD risk factor management including consideration of low dose aspirin therapy. Secondary prevention patients with high Lp(a) levels should consider adding PCSK9 inhibition to statin therapy.</p></div>","PeriodicalId":21156,"journal":{"name":"Progress in cardiovascular diseases","volume":null,"pages":null},"PeriodicalIF":9.1,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Preventive medicine and cardiac CT- Their move into mainstream medicine 预防医学和心脏 CT--向主流医学迈进

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-05-01 DOI: 10.1016/j.pcad.2024.05.006

M. Budoff

引用次数: 0

Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use 2023 年的冠状动脉钙化：低密度脂蛋白胆固醇（LDL-C）目标、非他汀类药物疗法和阿司匹林使用指南。

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-05-01 DOI: 10.1016/j.pcad.2024.05.004

Garshasb P. Soroosh , Erfan Tasdighi , Rishav Adhikari , Michael J. Blaha

{"title":"Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use","authors":"Garshasb P. Soroosh , Erfan Tasdighi , Rishav Adhikari , Michael J. Blaha","doi":"10.1016/j.pcad.2024.05.004","DOIUrl":"10.1016/j.pcad.2024.05.004","url":null,"abstract":"<div><p>Personalizing risk assessment and treatment decisions for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) rely on pooled cohort equations and increasingly coronary artery calcium (CAC) score. A growing body of evidence supports that elevated CAC scores correspond to progressively elevated ASCVD risk, and that scores of ≥100, ≥300, and ≥1000 denote risk that is equivalent to certain secondary prevention populations. This has led consensus guidelines to incorporate CAC score thresholds for guiding escalation of preventive therapy for lowering low-density lipoprotein cholesterol goals, initiation of non-statin lipid lowering medications, and use of low-dose daily aspirin. As data on CAC continues to grow, more decision pathways will incorporate CAC score cutoffs to guide management of blood pressure and cardiometabolic medications. CAC score is also being used to enrich clinical trial study populations for elevated ASCVD risk, and to screen for subclinical coronary atherosclerosis in patients who received chest imaging for other diagnostic purposes.</p></div>","PeriodicalId":21156,"journal":{"name":"Progress in cardiovascular diseases","volume":null,"pages":null},"PeriodicalIF":9.1,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assessing cardiorespiratory fitness in clinical and community settings: Lessons and advancements in the 100th year anniversary of VO2max 在临床和社区环境中评估心肺功能：VO2max 100 周年纪念的教训与进步。

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-03-01 DOI: 10.1016/j.pcad.2024.02.009

Matthew P. Harber , Jonathan Myers , Amanda R. Bonikowske , Adria Muntaner-Mas , Pablo Molina-Garcia , Ross Arena , Francisco B. Ortega

{"title":"Assessing cardiorespiratory fitness in clinical and community settings: Lessons and advancements in the 100th year anniversary of VO2max","authors":"Matthew P. Harber , Jonathan Myers , Amanda R. Bonikowske , Adria Muntaner-Mas , Pablo Molina-Garcia , Ross Arena , Francisco B. Ortega","doi":"10.1016/j.pcad.2024.02.009","DOIUrl":"10.1016/j.pcad.2024.02.009","url":null,"abstract":"<div><p>Cardiorespiratory fitness (CRF) is a well-established biomarker that has applications to all adults across the health and disease spectrum. Despite overwhelming evidence supporting the prognostic utility of CRF, it remains vastly underutilized. CRF is optimally measured via cardiopulmonary exercise testing which may not be feasible to implement on a large scale. Therefore, it is prudent to develop ways to accurately estimate CRF that can be applied in clinical and community settings. As such, several prediction equations incorporating non-exercise information that is readily available from routine clinical encounters have been developed that provide an adequate reflection of CRF that could be implemented to raise awareness of the importance of CRF. Further, technological advances in smartphone apps and consumer-grade wearables have demonstrated promise to provide reasonable estimates of CRF that are widely available, which could enhance the utilization of CRF in both clinical and community settings.</p></div>","PeriodicalId":21156,"journal":{"name":"Progress in cardiovascular diseases","volume":null,"pages":null},"PeriodicalIF":9.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139992259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

List of recent issues 近期期刊清单

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-03-01 DOI: 10.1016/S0033-0620(24)00059-8

引用次数: 0

How to interpret a cardiorespiratory fitness assessment – Key measures that provide the best picture of health, disease status and prognosis 如何解读心肺功能评估 - 最能反映健康状况、疾病状态和预后的关键指标。

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-03-01 DOI: 10.1016/j.pcad.2024.02.014

Cemal Ozemek , Joel Hardwick , Amanda Bonikowske , Jeffrey Christle , Charles German , Satyajit Reddy , Ross Arena , Mark Faghy

引用次数: 0

2023 update: The importance of cardiorespiratory fitness in the United States 2023 年更新：美国心肺功能的重要性

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-03-01 DOI: 10.1016/j.pcad.2024.01.020

Leonard A. Kaminsky , Jonathan Myers , Peter H. Brubaker , Barry A. Franklin , Amanda R. Bonikowske , Charles German , Ross Arena

{"title":"2023 update: The importance of cardiorespiratory fitness in the United States","authors":"Leonard A. Kaminsky , Jonathan Myers , Peter H. Brubaker , Barry A. Franklin , Amanda R. Bonikowske , Charles German , Ross Arena","doi":"10.1016/j.pcad.2024.01.020","DOIUrl":"10.1016/j.pcad.2024.01.020","url":null,"abstract":"<div><p>The American Heart Association issued a Policy Statement in 2013 that characterized the importance of cardiorespiratory fitness (CRF) as an essential marker of health outcomes and specifically the need for increased assessment of CRF. This statement summarized the evidence demonstrating that CRF is “<em>one of the most important correlates of overall health status and a potent predictor of an individual's future risk of cardiovascular disease</em>.” Subsequently, this Policy Statement led to the development of a National Registry for CRF (Fitness Registry and the Importance of Exercise: A National Data Base [FRIEND]) which established normative reference values for CRF for adults in the United States (US). This review provides an overview of the progress made in the past decade to further our understanding of the importance of CRF, specifically related to prevention and for clinical populations. Additionally, this review overviews the evolvement and additional uses of FRIEND and summarizes a hierarchy of assessment methods for CRF. In summary, continued efforts are needed to expand the representation of data from across the US, and to include data from pediatric populations, to further develop the CRF Reference Standards for the US as well as further develop Global CRF Reference Standards.</p></div>","PeriodicalId":21156,"journal":{"name":"Progress in cardiovascular diseases","volume":null,"pages":null},"PeriodicalIF":9.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139668812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Global status of cardiorespiratory fitness and physical activity – Are we improving or getting worse? 心肺功能和体育活动的全球状况--我们是在改善还是在恶化？

IF 9.1 2区医学

Progress in cardiovascular diseases Pub Date : 2024-03-01 DOI: 10.1016/j.pcad.2024.02.008

Andrew P. Hills , Sisitha Jayasinghe , Ross Arena , Nuala M. Byrne

{"title":"Global status of cardiorespiratory fitness and physical activity – Are we improving or getting worse?","authors":"Andrew P. Hills , Sisitha Jayasinghe , Ross Arena , Nuala M. Byrne","doi":"10.1016/j.pcad.2024.02.008","DOIUrl":"10.1016/j.pcad.2024.02.008","url":null,"abstract":"<div><p>Despite heightened recognition of the importance of cardiorespiratory fitness (CRF) to cardiovascular (CV) health, along with updated international consensus guidelines for physical activity (PA) and sedentary behavior (SB), significant proportions of the global adult population are physically inactive, and do not meet the threshold for CRF. Physical inactivity is considered a surrogate for low CRF given that the former is defined as not reaching the recommended minimum level of PA per week to derive a health benefit. Physical inactivity remains a major global public health problem despite decades of work by various United Nations agencies, and members of the international community to improve PA levels. Given the common coupling between physical inactivity and poor health status, it is reasonable to suggest that for a significant proportion of the global population, CRF is compromised by physical inactivity. This poses a longer-term risk to morbidity and mortality. Here we provide an indicative summary of the global status of CRF and PA and reference the implications for global health. We briefly reference opportunities moving forward, including reinforcement of the importance of engaging in movement from an early age, discouraging SB, and taking a life course approach to optimise healthy living for all.</p></div>","PeriodicalId":21156,"journal":{"name":"Progress in cardiovascular diseases","volume":null,"pages":null},"PeriodicalIF":9.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S003306202400029X/pdfft?md5=483ff39c851e9ee42b70d10eed095fa3&pid=1-s2.0-S003306202400029X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139992261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0